-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Beam Therapeutics Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$104 M, a 5.26% decline year-over-year.
- Beam Therapeutics Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$182 M, a 49.7% increase year-over-year.
- Beam Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$176 M, a 47.9% increase from 2022.
- Beam Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$338 M, a 13.8% increase from 2021.
- Beam Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$392 M, a 196% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)